Necrotizing enterocolitis (NEC) has largely been present in neonatal intensive care units for the past 60 years. NEC prevalence has corresponded with the continued development and sophistication of neonatal intensive care. Despite major efforts towards its eradication, NEC has persisted and appears to be increasing in some centers. The pathophysiology of this disease remains poorly understood. Several issues have hampered our quest to develop a better understanding of this disease. These include the fact that what we have historically termed ‘NEC' appears to be several different diseases. Animal models that are commonly used to study NEC pathophysiology and treatment do not directly reflect the most common form of the disease seen in human infants. The pathophysiology appears to be multifactorial, reflecting several different pathways to intestinal necrosis with different inciting factors. Spontaneous intestinal perforations, ischemic bowel disease secondary to cardiac anomalies as well as other entities that are clearly different from the most common form of NEC seen in preterm infants have been put into the same database. Here I describe some of the different forms of what has been called NEC and make some comments on its pathophysiology, where available studies suggest involvement of genetic factors, intestinal immaturity, hemodynamic instability, inflammation and a dysbiotic microbial ecology. Currently utilized approaches for the diagnosis of NEC are presented and innovative technologies for the development of diagnostic and predictive biomarkers are described. Predictions for future strategies are also discussed.

1.
Holman RC, Stoll BJ, Curns AT, Yorita KL, Steiner CA, Schonberger LB: Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol 2006;20:498-506.
2.
Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, Weldon C, Lillehei C, Valim C, Horbar JD, Jaksic T: Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009;44:1072-1075.
3.
Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, Poole WK, Blakely ML, Wright L, Higgins R; NICHD Neonatal Research Network: Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005;115:696-703.
4.
Martin CR, Dammann O, Allred E, Patel S, O'Shea TM, Kuban KC, Leviton A: Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia. J Pediatr 2010;157:751.e1-756.e1.
5.
Bisquera JA, Cooper TR, Berseth CL: Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics 2002;109:423-428.
6.
Ahle M, Drott P, Andersson RE: Epidemiology and trends of necrotizing enterocolitis in Sweden: 1987-2009. Pediatrics 2013;132:e443-e451.
7.
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T: Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-6.
8.
Feuille E, Nowak-Wegrzyn A: Definition, etiology, and diagnosis of food protein-induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol 2014;14:222-228.
9.
Pitt J, Barlow B, Heird WC: Protection against experimental necrotizing enterocolitis by maternal milk. I. Role of milk leukocytes. Pediatr Res 1977;11:906-909.
10.
Devillers N, Le Dividich J, Prunier A: Influence of colostrum intake on piglet survival and immunity. Animal 2011;5:1605-1612.
11.
McElroy SJ, Underwood MA, Sherman MP: Paneth cells and necrotizing enterocolitis: a novel hypothesis for disease pathogenesis. Neonatology 2013;103:10-20.
12.
Neu J, Walker WA: Necrotizing enterocolitis. N Engl J Med 2011;364:255-264.
13.
Murgas Torrazza R, Neu J: The developing intestinal microbiome and its relationship to health and disease in the neonate. J Perinatol 2011;31:S29-S34.
14.
Sharma R, Hudak ML: A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol 2013;40:27-51.
15.
Sharma R, Young C, Neu J: Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J Biomed Biotechnol 2010;2010:305879.
16.
Lin PW, Stoll BJ: Necrotising enterocolitis. Lancet 2006;368:1271-1283.
17.
Kasivajjula H, Maheshwari A: Pathophysiology and current management of necrotizing enterocolitis. Indian J Pediatr 2014;81:489-497.
18.
Gordon PV, Swanson JR: Necrotizing enterocolitis is one disease with many origins and potential means of prevention. Pathophysiology 2014;21:13-19.
19.
Torrazza RM, Li N, Neu J: Decoding the enigma of necrotizing enterocolitis in premature infants. Pathophysiology 2014;21:21-27.
20.
Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, Ment LR, Gruen JR; Neonatal Genetics Study Group: Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006;117:1901-1906.
21.
Treszl A, Heninger E, Kalman A, Schuler A, Tulassay T, Vasarhelyi B: Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 2003;38:1374-1378.
22.
Szebeni B, Szekeres R, Rusai K, Vannay A, Veres G, Treszl A, Arato A, Tulassay T, Vasarhelyi B: Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants. J Pediatr Gastroenterol Nutr 2006;42:27-31.
23.
Moonen RM, Paulussen AD, Souren NY, Kessels AG, Rubio-Gozalbo ME, Villamor E: Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis. Pediatr Res 2007;62:188-190.
24.
Sampath V, Le M, Lane L, Patel AL, Cohen JD, Simpson PM, Garland JS, Hines RN: The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J Surg Res 2011;169:e51-e57.
25.
Hackam DJ, Afrazi A, Good M, Sodhi CP: Innate immune signaling in the pathogenesis of necrotizing enterocolitis. Clin Dev Immunol 2013;2013:475415.
26.
Claud EC, Walker WA: Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. Faseb J 2001;15:1398-1403.
27.
Lin PW, Stoll BJ: Necrotising enterocolitis. Lancet 2006;368:1271-1283.
28.
Mai V, Torrazza RM, Ukhanova M, Wang X, Sun Y, Li N, Shuster J, Sharma R, Hudak ML, Neu J: Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants. PLoS One 2013;8:e52876.
29.
Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, Antonopoulos DA, Chang EB, Claud EC: 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009;3:944-954.
30.
Morrow AL, Lagomarcino AJ, Schibler KR, Taft DH, Yu Z, Wang B, Altaye M, Wagner M, Gevers D, Ward DV, Kennedy MA, Huttenhower C, Newburg DS: Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome 2013;1:13.
31.
Li Q, Wang C, Tang C, Li N, Li J: Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn's disease. PLoS One 2012;7:e34939.
32.
Clark RH, Bloom BT, Spitzer AR, Gerstmann DR: Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006;117:1979-1987.
33.
Miyasaka EA, Feng Y, Poroyko V, Falkowski NR, Erb-Downward J, Gillilland MG 3rd, Mason KL, Huffnagle GB, Teitelbaum DH: Total parenteral nutrition-associated lamina propria inflammation in mice is mediated by a MyD88-dependent mechanism. J Immunol 2013;190:6607-6615.
34.
Demehri FR, Barrett M, Ralls MW, Miyasaka EA, Feng Y, Teitelbaum DH: Intestinal epithelial cell apoptosis and loss of barrier function in the setting of altered microbiota with enteral nutrient deprivation. Frontiers in Cellular and Infection Microbiology 2013;3:105.
35.
Stecher B: Finding a sugary foothold: how antibiotics pave the way for enteric pathogens. Cell Host Microbe 2013;14:225-227.
36.
Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM: Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013;502:96-99.
37.
Duncan SH, Louis P, Thomson JM, Flint HJ: The role of pH in determining the species composition of the human colonic microbiota. Environl Microbiol 2009;11:2112-2122.
38.
Chung EY, Yardley J: Are there risks associated with empiric acid suppression treatment of infants and children suspected of having gastroesophageal reflux disease? Hosp Pediatr 2013;3:16-23.
39.
Rogier EW, Frantz AL, Bruno ME, Wedlund L, Cohen DA, Stromberg AJ, Kaetzel CS: Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc Natl Acad Sci USA 2014;111:3074-3079.
40.
Neu J, Mihatsch WA, Zegarra J, Supapannachart S, Ding ZY, Murguia-Peniche T: Intestinal mucosal defense system. Part 1. Consensus recommendations for immunonutrients. J Pediatr 2013;162:S56-S63.
41.
Hunt KM, Foster JA, Forney LJ, Schutte UM, Beck DL, Abdo Z, Fox LK, Williams JE, McGuire MK, McGuire MA: Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One 2011;6:e21313.
42.
Ward TL, Hosid S, Ioshikhes I, Altosaar I: Human milk metagenome: a functional capacity analysis. BMC Microbiol 2013;13:116.
43.
Jeurink PV, van Bergenhenegouwen J, Jimenez E, Knippels LM, Fernandez L, Garssen J, Knol J, Rodriguez JM, Martin R: Human milk: a source of more life than we imagine. Benef Microbes 2013;4:17-30.
44.
Kleinman RE, Walker WA: The enteromammary immune system: an important new concept in breast milk host defense. Dig Dis Sci 1979;24:876-882.
45.
Riskin A, Almog M, Peri R, Halasz K, Srugo I, Kessel A: Changes in immunomodulatory constituents of human milk in response to active infection in the nursing infant. Pediatr Res 2012;71:220-225.
46.
Neu J, Sullivan S: Baby and breast: a dynamic interaction. Pediatr Res 2012;71:135.
47.
Dodd VL: Implications of kangaroo care for growth and development in preterm infants. J Obstet Gynecol Neonatal Nurs 2005;34:218-232.
48.
Neu J: The ‘myth' of asphyxia and hypoxia-ischemia as primary causes of necrotizing enterocolitis. Biol Neonate 2005;87:97-98.
49.
Young CM, Kingma SD, Neu J: Ischemia-reperfusion and neonatal intestinal injury. J Pediatr 2011;158:e25-e28.
50.
Cerbo RM, Maragliano R, Pozzi M, Strocchio L, Mostert M, Manzoni P, Stronati M: Global perfusion assessment and tissue oxygen saturation in preterm infants: where are we? Early Hum Dev 2013;89:S44-S46.
51.
Hollingsworth CL, Rice HE: The Duke Abdominal Assessment Scale: initial experience. Expert Rev Gastroenterol Hepatol 2010;4:569-574.
52.
Rehan VK, Seshia MM, Johnston B, Reed M, Wilmot D, Cook V: Observer variability in interpretation of abdominal radiographs of infants with suspected necrotizing enterocolitis. Clin Pediatr 1999;38:637-643.
53.
McBride WJ, Roy S, Brudnicki A, Stringel G: Correlation of complex ascites with intestinal gangrene and perforation in neonates with necrotizing enterocolitis. J Pediatr Surg 2010;45:887-889.
54.
Thuijls G, Derikx JP, van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, Van der Zee DC, Brouwers HA, Verhoeven BH, van Heurn LW: Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010;251:1174-1180.
55.
Ng EW, Poon TC, Lam HS, Cheung HM, Ma TP, Chan KY, Wong RP, Leung KT, Lam MM, Li K: Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg 2013;258:1111-1118.
56.
Benkoe T, Reck C, Pones M, Weninger M, Gleiss A, Stift A, Rebhandl W: Interleukin-8 predicts 60-day mortality in premature infants with necrotizing enterocolitis. J Pediatr Surg 2014;49:385-389.
57.
Young C, Sharma R, Handfield M, Mai V, Neu J: Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention? Pediatr Res 2009;65:91R-97R.
58.
Menon G, Williams TC: Human milk for preterm infants: why, what, when and how? Arch Dis Child Fetal Neonatal Ed 2013;98:F559-F562.
59.
Arslanoglu S, Corpeleijn W, Moro G, Braegger C, Campoy C, Colomb V, Decsi T, Domellof M, Fewtrell M, Hojsak I: Donor Human Milk for Preterm Infants: Current Evidence and Research Directions. J Pediatr Gastroenterol Nutr 2013;57:535-542.
60.
Burton OM: The American Academy of Pediatrics and breastfeeding. Breastfeed Med 2012;7:334-336.
61.
Ramani M, Ambalavanan N: Feeding practices and necrotizing enterocolitis. Clin Perinatol 2013;40:1-10.
62.
Hay WW Jr: Strategies for feeding the preterm infant. Neonatology 2008;94:245-254.
63.
Torrazza RM, Neu J: Evidence-Based Guidelines for Optimization of Nutrition for the Very Low Birthweight Infant. NeoReviews 2013;14:e340-e349.
64.
Parker LA, Neu J, Torrazza RM, Li Y: Scientifically Based Strategies for Enteral Feeding in Premature Infants. NeoReviews 2013;14:e350-e359.
65.
Gephart SM, Hanson CK: Preventing necrotizing enterocolitis with standardized feeding protocols: not only possible, but imperative. Adv Neonatal Care 2013;13:48-54.
66.
Morgan JA, Young L, McGuire W: Pathogenesis and prevention of necrotizing enterocolitis. Curr Opin Infect Dis 2011;24:183-189.
67.
Neu J, Walker WA: Necrotizing enterocolitis. N Engl J Med 2011;364:255-264.
68.
Deshpande G, Rao S, Patole S, Bulsara M: Updated Meta-analysis of Probiotics for Preventing Necrotizing Enterocolitis in Preterm Neonates. Pediatrics 2010;125:921-930.
69.
Modi N: Probiotics and Necrotising Enterocolitis: the devil (as always) is in the detail. Commentary on N. Ofek Shlomai et al: Probiotics for preterm neonates: what will it take to change clinical practice? (Neonatology 2014;105:64-70). Neonatology 2014;105:71-73.
70.
Neu J: Routine Probiotics for Premature Infants: Let's Be Careful! J Pediatr 2011;158:672-674.
71.
Claud EC: First do no harm. J Pediatr Pharmacol Ther 2012;17:298-301.
72.
Martin CR: Probiotics for the prevention of necrotizing enterocolitis: not just which ones but also why? J Pediatr Gastroenterol Nutr 2013;57:3.
73.
Kataria J, Li N, Wynn JL, Neu J: Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev 2009;67:546-550.
74.
Murgas Torrazza R, Li N, Young C, Kobeissy F, Chow M, Chen S, Mai V, Sharma R, Hudak M, Shuster J, Neu J: Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology 2013;104:234-242.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.